14/02/2017 - 16:55

Marijuana trials for epileptic children

14/02/2017 - 16:55


Save articles for future reference.

In a bold move, ASX-listed MGC Pharmaceuticals has announced it will undertake a new clinical trial to detremine how medicinal cannabis could potentially treat young epilepsy sufferers. The Perth-based company believes the study could present a significant commercial opportunity in the medical marijuana space and it may add a third revenue stream for the company. 

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options